Open access · OA
via Europe PMC
Novel Flavonoid Senotherapeutics Identified by Phenotypic Drug Discovery Reduce Senescence and Improve Multiple Markers of Healthspan
Zhang L, Salekeen R, Soto‐Palma C, Wu Q, He Y, Elsallabi O, Bdiri B, Hughes B, Nunes A, Xu W, Zhang B, Mohamed A, McGowan S, Angelini L, O'Kelly R
Aging cell · 2026
Abstract
This study in Aging Cell, 2026, identifies novel flavonoid senotherapeutics via phenotypic drug discovery. The research examines their effect on senescence(definition).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
L, Z., R, S., C, S., Q, W., Y, H., O, E., B, B., B, H., A, N., W, X., B, Z., A, M., S, M., L, A., R, O., T, K., L, N., & P., R. (2026). Novel Flavonoid Senotherapeutics Identified by Phenotypic Drug Discovery Reduce Senescence and Improve Multiple Markers of Healthspan. <em>Aging cell</em>. https://europepmc.org/article/PMC/PMC13640056
Vancouver
L Z, R S, C S, Q W, Y H, O E, et al. Novel Flavonoid Senotherapeutics Identified by Phenotypic Drug Discovery Reduce Senescence and Improve Multiple Markers of Healthspan. Aging cell. 2026.
BibTeX
@article{zhang2026NovelF,
title = {Novel Flavonoid Senotherapeutics Identified by Phenotypic Drug Discovery Reduce Senescence and Improve Multiple Markers of Healthspan},
author = {Zhang L and Salekeen R and Soto‐Palma C and Wu Q and He Y and Elsallabi O and Bdiri B and Hughes B and Nunes A and Xu W and Zhang B and Mohamed A and McGowan S and Angelini L and O'Kelly R and Kamenecka T and Niedernhofer L and Robbins P.},
journal = {Aging cell},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2026
Open access · CC-BY
Novel Flavonoid Senotherapeutics Identified by Phenotypic Drug Discovery Reduce Senescence and Improve Multiple Markers of Healthspan
Aging cell 2026
Citation only
Novel Flavonoid Senotherapeutics Identified by Phenotypic Drug Discovery Reduce Senescence and Improve Multiple Markers of Healthspan.
Nature 2005
Open access · OA
Senescence in premalignant tumours
Bone Research 2026
Open access · CC-BY
Dasatinib and quercetin senolytic treatment delays early onset intervertebral disc degeneration in SM/J mice
Frontiers in immunology 2026
Open access · OA
The MTRNR2L gene family and age-related macular degeneration.
Aging Cell 2023
Open access · CC-BY